| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AA genotype of deSNP rs6726639 of MERTK gene is associated with development of Hepatocellular Carcinoma after eradication of Hepatitis C Virus infection
|
Di Marco, L.
|
|
2019
|
51 |
S1 |
p. e7
|
artikel
|
| 2 |
Accuracy of diagnostic evaluation of hepatocellular carcinoma with LI-RADS
|
Barabino, M.
|
|
2019
|
51 |
S1 |
p. e41
|
artikel
|
| 3 |
A close monitoring of virological and immunological hepatitis B markers can improve the diagnosis of HBV reactivation in HBsAg-negative/anti-HBc-positive patients with oncohematological diseases
|
Salpini, R.
|
|
2019
|
51 |
S1 |
p. e67
|
artikel
|
| 4 |
Acquisition of stem-like features in human cholangiocarcinoma is associated with an oxidative metabolism
|
Raggi, C.
|
|
2019
|
51 |
S1 |
p. e34
|
artikel
|
| 5 |
Acute presentation and male predominance in a series of adult patients with seronegative autoimmune hepatitis
|
Bensi, C.
|
|
2019
|
51 |
S1 |
p. e20
|
artikel
|
| 6 |
AGT gene polymorphisms predict early dose modification of sorafenib for dermatological adverse events: towards tailored medicine for patients with hepatocellular carcinoma
|
Iavarone, M.
|
|
2019
|
51 |
S1 |
p. e38
|
artikel
|
| 7 |
A.I.S.F. 2019: Abstracts evaluation procedure
|
|
|
2019
|
51 |
S1 |
p. e70
|
artikel
|
| 8 |
Algorithms using noninvasive tests can accurately identify patients with advanced fibrosis due to NASH: data from the STELLAR clinical trials
|
Lampertico, P.
|
|
2019
|
51 |
S1 |
p. e25-e26
|
artikel
|
| 9 |
Alterations in stearoyl-CoA-desaturase index and metalloproteinase activity in nutritional versus genetic rat models of NAFLD
|
Siciliano, V.
|
|
2019
|
51 |
S1 |
p. e31
|
artikel
|
| 10 |
A new regulator of mitochondrial OXPHOS in hepatocytes and HCC cell lines: the AAA+ ATPase RuvBL1
|
Simeone, I.
|
|
2019
|
51 |
S1 |
p. e39
|
artikel
|
| 11 |
An intention-to-treat competing-risk model for candidates with hepatocellular cancer waiting for liver transplantation
|
Lai, Q.
|
|
2019
|
51 |
S1 |
p. e13
|
artikel
|
| 12 |
Association between black race and presentation and liver-related outcomes of patients with autoimmune hepatitis
|
de Boer, Y.S.
|
|
2019
|
51 |
S1 |
p. e18-e19
|
artikel
|
| 13 |
ATG7 genetic variant and defective autophagy: a novel risk factor for non-alcoholic fatty liver disease progression in patients with type 2 diabetes mellitus
|
Pelusi, S.
|
|
2019
|
51 |
S1 |
p. e4-e5
|
artikel
|
| 14 |
Can we revise Baveno VI criteria using spleen elastography?
|
Giuffrè, M.
|
|
2019
|
51 |
S1 |
p. e45
|
artikel
|
| 15 |
Capecitabine in advanced hepatocellular carcinoma: a multicenter experience
|
Pelizzaro, F.
|
|
2019
|
51 |
S1 |
p. e40
|
artikel
|
| 16 |
Changes in 13C-aminopyrine breath test predict liver-related events and death in patients with HCV-related previous decompensated child A5 or child A6 to B cirrhosis who achieve SVR after DAA therapy
|
Petta, S.
|
|
2019
|
51 |
S1 |
p. e68
|
artikel
|
| 17 |
Characteristics of hepatocellular carcinoma patients with long-term survival: an ITA.LI.CA report
|
Pelizzaro, F.
|
|
2019
|
51 |
S1 |
p. e38
|
artikel
|
| 18 |
Characterization of baseline factors associated with treatment outcome in HCV-infected patients naive to direct acting antivirals: particular focus on natural resistance
|
Barbaliscia, S.
|
|
2019
|
51 |
S1 |
p. e65-e66
|
artikel
|
| 19 |
Characterizing compensated cirrhosis (CC) patients with potential etiology of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH): findings from large Italian administrative databases
|
Marchesini, G.
|
|
2019
|
51 |
S1 |
p. e49-e50
|
artikel
|
| 20 |
Chemokine changes during direct antiviral agents (DAA) therapy in patients with HCV infection or reinfection after liver transplantation: preliminary insights on their possible correlates
|
Colucci, G.
|
|
2019
|
51 |
S1 |
p. e66
|
artikel
|
| 21 |
Cholangiocarcinoma primary, circulating and metastatic stem-like cells
|
Correnti, M.
|
|
2019
|
51 |
S1 |
p. e32
|
artikel
|
| 22 |
Circulating miR-3185 as a predictive marker for overall survival in patients with hepatocellular carcinoma
|
Pratama, M.Y.
|
|
2019
|
51 |
S1 |
p. e36
|
artikel
|
| 23 |
Clinical but not genetic variables predict the development of hepatocellular carcinoma in hepatitis C cirrhotic patients treated with direct acting antivirals: a 3-year study in 509 patients
|
Degasperi, E.
|
|
2019
|
51 |
S1 |
p. e67
|
artikel
|
| 24 |
Clinical impact of comorbidities in an Italian NAFLD cohort
|
Miele, L.
|
|
2019
|
51 |
S1 |
p. e32
|
artikel
|
| 25 |
Clinical presentation and etiological spectrum of idiopathic non-cirrhotic portal hypertension (INCPH): data from the Italian Registry
|
Primignani, M.
|
|
2019
|
51 |
S1 |
p. e49
|
artikel
|
| 26 |
Combined therapy with Sorafenib and FAK inhibitor TAE226 impairs hepatocellular carcinoma growth by interfering with epigenetic modifications and stemness markers
|
Romito, I.
|
|
2019
|
51 |
S1 |
p. e36
|
artikel
|
| 27 |
De novo neoplasms after liver transplantation: donor gender and age influence
|
Shalaby, S.
|
|
2019
|
51 |
S1 |
p. e50
|
artikel
|
| 28 |
Development of a model based on case-mix analysis to predict 6-month patient survival after liver transplantation: a multicenter Italian study
|
Avolio, A.
|
|
2019
|
51 |
S1 |
p. e11-e12
|
artikel
|
| 29 |
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
|
Cabibbo, G.
|
|
2019
|
51 |
S1 |
p. e36-e37
|
artikel
|
| 30 |
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis
|
Cristoferi, L.
|
|
2019
|
51 |
S1 |
p. e1
|
artikel
|
| 31 |
Early referral to transplant centers is a prognostic factor influencing outcomes of pediatric liver transplantation
|
Angelico, R.
|
|
2019
|
51 |
S1 |
p. e53
|
artikel
|
| 32 |
Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: safety and survival
|
Mazza, S.
|
|
2019
|
51 |
S1 |
p. e35
|
artikel
|
| 33 |
Editorial Board
|
|
|
2019
|
51 |
S1 |
p. i-ii
|
artikel
|
| 34 |
Effectiveness and safety of Sofosbuvir/Velpatasvir/Voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: a real-life study from the Navigatore Lombardia and Veneto Networks
|
Degasperi, E.
|
|
2019
|
51 |
S1 |
p. e15
|
artikel
|
| 35 |
Effectiveness, safety and T-cell activation profiles of long-term Myrcludex B treatment in two patients with HDV related compensated cirrhosis
|
Loglio, A.
|
|
2019
|
51 |
S1 |
p. e62
|
artikel
|
| 36 |
Effects of DAAs (direct-acting antivirals) on cardiac function and structure in hepatitis c (HCV) patients with low-mild liver fibrosis
|
Dalbeni, A.
|
|
2019
|
51 |
S1 |
p. e58
|
artikel
|
| 37 |
Effects of HCV eradication by DAA on oxidative stress parameters in patients with chronic hepatitis C
|
Salomone, F.
|
|
2019
|
51 |
S1 |
p. e59
|
artikel
|
| 38 |
Efficacy and safety of Elbasvir/Grazoprevir in a large real-life cohort of HCV-infected patients
|
Gambato, M.
|
|
2019
|
51 |
S1 |
p. e55-e56
|
artikel
|
| 39 |
Epidemiology of porphyrias in Italy: rare complex diseases with liver involvement- data from the registry of Gruppo Italiano Porfiria (GrIP)
|
Ventura, P.
|
|
2019
|
51 |
S1 |
p. e20
|
artikel
|
| 40 |
Extracellular vesicles derived from CHK2 mRNA as a possible predictive marker of HCC in HCV-infected patients
|
Cavallini, L.
|
|
2019
|
51 |
S1 |
p. e58
|
artikel
|
| 41 |
Extra-hepatic tumor recurrence after directly-acting-antiviral (DAA) therapy in HCV patients
|
Torres, M.C. Plaz
|
|
2019
|
51 |
S1 |
p. e63
|
artikel
|
| 42 |
Fondaparinux vs low molecular weight heparin in the treatment of non malignant portal vein thrombosis in patients cirrhosis
|
Senzolo, M.
|
|
2019
|
51 |
S1 |
p. e42
|
artikel
|
| 43 |
FXR rs35724 G>C variant modulates cholesterol levels, carotid atherosclerosis and liver damage in non-alcoholic fatty liver
|
Grimaudo, S.
|
|
2019
|
51 |
S1 |
p. e26
|
artikel
|
| 44 |
Ganglioside composition correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cell adhesion
|
Mannini, A.
|
|
2019
|
51 |
S1 |
p. e7
|
artikel
|
| 45 |
HCV-Ab sero-prevalence in persons who inject drugs in a Province of Southern Italy: results of a screening program
|
De Luna, A.
|
|
2019
|
51 |
S1 |
p. e17
|
artikel
|
| 46 |
Hepatitis C virus prevalence in a cohort of jailbirds in a city of Southern Italy
|
Caruso, R.
|
|
2019
|
51 |
S1 |
p. e59
|
artikel
|
| 47 |
Hepatocyte expression of the protein kinase ERK5 regulates insulin sensitivity
|
Di Maira, G.
|
|
2019
|
51 |
S1 |
p. e28
|
artikel
|
| 48 |
Hepatocyte-specific deletion of ERK5 modulates liver regeneration in mice
|
Di Maira, G.
|
|
2019
|
51 |
S1 |
p. e43
|
artikel
|
| 49 |
HEV infection: an emerging disease. One year observation in a tertiary care center in Milan
|
De Nicola, S.
|
|
2019
|
51 |
S1 |
p. e24
|
artikel
|
| 50 |
Human duodenal submucosal glands contain stem cells with potential for liver and pancreatic regenerative medicine
|
Carpino, G.
|
|
2019
|
51 |
S1 |
p. e3
|
artikel
|
| 51 |
Immunomorphological and molecular panel help identify intermediate cells in mixed primary liver cancers
|
Malvi, D.
|
|
2019
|
51 |
S1 |
p. e35
|
artikel
|
| 52 |
Impact of diastolic dysfunction (LVDD) on clinical response and prognosis after transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites
|
Venon, W. Debernardi
|
|
2019
|
51 |
S1 |
p. e11
|
artikel
|
| 53 |
Impact of genetic polymorphisms associated with NAFLD on hepatic and vascular complications in diabetes
|
Lombardi, R.
|
|
2019
|
51 |
S1 |
p. e28-e29
|
artikel
|
| 54 |
Impact on post liver transplant outcomes of response to treatment with terlipressin and albumin in patients with hepatorenal syndrome
|
Vettore, E.
|
|
2019
|
51 |
S1 |
p. e50-e51
|
artikel
|
| 55 |
Incidence and outcome of portal vein thrombosis in 817 HBV and HCV cirrhotic patients under antiviral treatment: a single center longitudinal study
|
Tosetti, G.
|
|
2019
|
51 |
S1 |
p. e10
|
artikel
|
| 56 |
Incidence and prognostic factors of “de novo” development/worsening of esophageal varices in HCV-related chronic advanced liver disease after sustained virologic response achieved by direct oral antiviral agents
|
Tosetti, G.
|
|
2019
|
51 |
S1 |
p. e47
|
artikel
|
| 57 |
Increased portal pressure is associated with elevated liver enzymes during pregnancy: the role of doppler-ultrasound and liver stiffness measurement
|
Serra, C.
|
|
2019
|
51 |
S1 |
p. e22-e23
|
artikel
|
| 58 |
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients
|
Ravaioli, F.
|
|
2019
|
51 |
S1 |
p. e55
|
artikel
|
| 59 |
INOS-mediated decrease of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion
|
Di Pasqua, L.G.
|
|
2019
|
51 |
S1 |
p. e45
|
artikel
|
| 60 |
Is poor vitamin status a reliable target for treatment of symptomatic patients with hepatic acute porphyrias?
|
Ventura, P.
|
|
2019
|
51 |
S1 |
p. e23-e24
|
artikel
|
| 61 |
Key mutations in HBsAg C-terminus correlate with lower HBsAg levels in vivo, hinder HBsAg release in vitro and affect HBsAg structural stability in HBeAg-negative chronic HBV genotype D infection
|
Piermatteo, L.
|
|
2019
|
51 |
S1 |
p. e60
|
artikel
|
| 62 |
Lack of CCL2 limits the development of HCC in a model of obesity-associated carcinogenesis
|
Vivoli, E.
|
|
2019
|
51 |
S1 |
p. e34
|
artikel
|
| 63 |
Laparoscopic liver resection versus transarterial chemoembolization for hepatocellular carcinoma in BCLC B patients: a propensity score analysis
|
Bertacco, A.
|
|
2019
|
51 |
S1 |
p. e13
|
artikel
|
| 64 |
Laparoscopic liver resection versus transarterial chemoembolization for hepatocellular carcinoma in child B cirrhosis: a propensity score analysis
|
Bertacco, A.
|
|
2019
|
51 |
S1 |
p. e52
|
artikel
|
| 65 |
Liver stiffness-spleen size-to-platelet ratio risk score (LSPS) detects esophageal varices and HCC risk in HCV- and HBV-related cirrhosis responsive to DAA
|
Imperatrice, B.
|
|
2019
|
51 |
S1 |
p. e48
|
artikel
|
| 66 |
Longitudinal prognostic value of the most common algorithms for fibrosis in non-alcoholic fatty liver disease. An international study in non-cirrhotic, biopsy-proven patients
|
Younes, R.
|
|
2019
|
51 |
S1 |
p. e5
|
artikel
|
| 67 |
Long-term albumin administration in patients with cirrhosis and uncomplicated ascites: the use of serum albumin concentration for personalizing treatment
|
Zaccherini, G.
|
|
2019
|
51 |
S1 |
p. e9
|
artikel
|
| 68 |
Long-term liver function changes and related risk factors after direct-acting antiviral therapy in HCV-infected cirrhotic patients: results from a prospective web-based regional platform
|
Russo, F.P.
|
|
2019
|
51 |
S1 |
p. e16
|
artikel
|
| 69 |
Magnetic resonance risk score and liver stiffness by transient elastography have complementary prognostic values in patients with Primary Sclerosing Cholangitis
|
Cazzagon, N.
|
|
2019
|
51 |
S1 |
p. e2
|
artikel
|
| 70 |
MerTK-mediated cytokine secretion mediates a cross-talk between M2c macrophages and hepatic stellate cells (HSC) to induce fibrosis
|
Pastore, M.
|
|
2019
|
51 |
S1 |
p. e44
|
artikel
|
| 71 |
Metabolomic profile of morbidly obese NAFLD: effect of weight loss by exenatide or diet
|
Patrício, B.
|
|
2019
|
51 |
S1 |
p. e30
|
artikel
|
| 72 |
Mixed cryoglobulinemia patients with persisting symptoms after SVR are characterized by B-cell clonality markers
|
Lorini, S.
|
|
2019
|
51 |
S1 |
p. e69
|
artikel
|
| 73 |
Models of care for the management and treatment of hepatitis C virus infection among people who inject drugs
|
Conti, F.
|
|
2019
|
51 |
S1 |
p. e60-e61
|
artikel
|
| 74 |
NASH-related liver carcinogenesis is critically affected by hypoxia-inducible factor 2α
|
Foglia, B.
|
|
2019
|
51 |
S1 |
p. e8
|
artikel
|
| 75 |
Necroptosis is associated with a better survival in intrahepatic cholangiocarcinoma
|
Sacchi, D.
|
|
2019
|
51 |
S1 |
p. e2-e3
|
artikel
|
| 76 |
Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) patients with advanced liver disease had high burden of comorbidities, healthcare resource utilization (HCRU) and costs: results from Italian administrative databases
|
Marchesini, G.
|
|
2019
|
51 |
S1 |
p. e27
|
artikel
|
| 77 |
Non-invasive markers of fibrosis at 3 years of follow-up in liver transplant recipients with moderate/severe hepatitis C recurrence, successfully treated with DAAs
|
Martini, S.
|
|
2019
|
51 |
S1 |
p. e51-e52
|
artikel
|
| 78 |
Novel insights in primary biliary cholangitis (PBC) epidemiology using administrative records
|
Gerussi, A.
|
|
2019
|
51 |
S1 |
p. e3-e4
|
artikel
|
| 79 |
Novel super stealth immunoliposomes for cancer targeted delivery of doxorubicin: an innovative strategy to reduce liver toxicity
|
Gabbia, D.
|
|
2019
|
51 |
S1 |
p. e21
|
artikel
|
| 80 |
NS5A gene analysis by next generation sequencing in HCV nosocomial transmission clusters of HCV genotype 1b infected patients
|
Bellocchi, M.C.
|
|
2019
|
51 |
S1 |
p. e62
|
artikel
|
| 81 |
Nuclear orphan receptor COUP-TF2 induces anoikis resistance, amoeboid migration and metastatic potential in hepatocellular carcinoma (HCC)
|
Ceni, E.
|
|
2019
|
51 |
S1 |
p. e37
|
artikel
|
| 82 |
Outcome of critically ill patients with cirrhosis and ACLF after ICU admission
|
Ferrarese, A.
|
|
2019
|
51 |
S1 |
p. e14
|
artikel
|
| 83 |
Overall survival and incidence of liver-related events in a cohort of cirrhotic patients treated with direct antiviral agents: results from a multicenter study
|
Masetti, C.
|
|
2019
|
51 |
S1 |
p. e57
|
artikel
|
| 84 |
Percutaneous microwave (MW) is superior to radiofrequency ablation (RFA) to induce complete response in cirrhotic patients with very early and early hepatocellular carcinoma (HCC)
|
Mosso, E.
|
|
2019
|
51 |
S1 |
p. e40
|
artikel
|
| 85 |
PNPLA3 rs738409 C>G variant predicts occurrence of liver-related events and death in non-alcoholic fatty liver
|
Grimaudo, S.
|
|
2019
|
51 |
S1 |
p. e5-e6
|
artikel
|
| 86 |
Portal endothelial damage in cirrhosis
|
Shalaby, S.
|
|
2019
|
51 |
S1 |
p. e9-e10
|
artikel
|
| 87 |
Preclinical evaluation of Endothelial Dysfunction by peripheral artery tonometry and its correlations with untargeted metabolomic profiles in NAFLD
|
Troisi, J.
|
|
2019
|
51 |
S1 |
p. e27-e28
|
artikel
|
| 88 |
Predictors of nosocomial acute-on-chronic liver failure for the risk stratification of patients with cirrhosis admitted to hospital with acute decompensation
|
Zaccherini, G.
|
|
2019
|
51 |
S1 |
p. e42
|
artikel
|
| 89 |
Pre-liver transplant cardiovascular risk profile and correlation with early post-transplant cardiac events
|
Martini, S.
|
|
2019
|
51 |
S1 |
p. e52
|
artikel
|
| 90 |
Prevalence and pattern of atherosclerotic changes in primary biliary cholangitis and in non-alcoholic fatty liver disease
|
Ponziani, F.R.
|
|
2019
|
51 |
S1 |
p. e24
|
artikel
|
| 91 |
Prevalence of patients with non-alcoholic fatty liver disease: from primary care to tertiary centers. The Turin experience
|
Armandi, A.
|
|
2019
|
51 |
S1 |
p. e29
|
artikel
|
| 92 |
Procoagulant imbalance in chronic hepatitis C and its relationship with cardiovascular and liver damage
|
Sigon, G.
|
|
2019
|
51 |
S1 |
p. e57
|
artikel
|
| 93 |
Real life data on elbasvir/grazoprevir efficacy, safety and drug-drug interaction profile in patients with chronic hepatitis C viral infection: a prospective analysis in the PITER cohort
|
Quaranta, M.G.
|
|
2019
|
51 |
S1 |
p. e61
|
artikel
|
| 94 |
Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in HCV infected patients with chronic kidney disease
|
Aglitti, A.
|
|
2019
|
51 |
S1 |
p. e66
|
artikel
|
| 95 |
Resistance test guided retreatment of HCV infected patients with a previous failure to a NS5A inhibitor-containing regimen: the Italian Vironet C real life experience
|
Di Maio, V.C.
|
|
2019
|
51 |
S1 |
p. e53-e54
|
artikel
|
| 96 |
Response to treatment and mortality in patients with acute-on-chronic liver failure according to the new definition of hepatorenal syndrome: a single center 3-year retrospective analysis
|
Giovo, I.
|
|
2019
|
51 |
S1 |
p. e44
|
artikel
|
| 97 |
Risk factors associated with NASH in obese people who underwent bariatric surgery
|
Raimondo, G.
|
|
2019
|
51 |
S1 |
p. e6
|
artikel
|
| 98 |
Risk of liver disease in first-degree relatives of patients with advanced NAFLD: initial data from an Italian cohort study
|
Cespiati, A.
|
|
2019
|
51 |
S1 |
p. e23
|
artikel
|
| 99 |
Role of Bisphenol A on cell biology: effect on proliferation, oxidative stress and steroid hormones metabolism of HepG2 cells
|
Dallio, M.
|
|
2019
|
51 |
S1 |
p. e46
|
artikel
|
| 100 |
Safety and effectiveness of Regorafenib in recurrent HCC after liver transplantation and progression on Sorafenib: a real-life multicentre study
|
Invernizzi, F.
|
|
2019
|
51 |
S1 |
p. e12
|
artikel
|
| 101 |
Screening and accelerated vaccination against hepatitis B virus infection in prison: a multicentre pilot study
|
Stasi, C.
|
|
2019
|
51 |
S1 |
p. e69
|
artikel
|
| 102 |
Screening strategies for Hepatitis C Virus elimination in Italy
|
Kondili, L.A.
|
|
2019
|
51 |
S1 |
p. e68
|
artikel
|
| 103 |
Selenoprotein P levels discriminate the degree of hepatic steatosis and are related to the NAS score in patients with non-alcoholic fatty liver disease
|
Rosso, C.
|
|
2019
|
51 |
S1 |
p. e26
|
artikel
|
| 104 |
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity
|
Scamporrino, A.
|
|
2019
|
51 |
S1 |
p. e4
|
artikel
|
| 105 |
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis
|
Gerussi, A.
|
|
2019
|
51 |
S1 |
p. e18
|
artikel
|
| 106 |
Surface enhanced Raman spectroscopy as a diagnostic tool for circulating miRNA detection in HCC: the SERMI4cancer project
|
Pascut, D.
|
|
2019
|
51 |
S1 |
p. e39
|
artikel
|
| 107 |
The administration of a high-fat diet alters bile acid composition and hepatic drug metabolism in rats
|
Gabbia, D.
|
|
2019
|
51 |
S1 |
p. e22
|
artikel
|
| 108 |
The clinical course of recurrent versus refractory ascites in outpatients with cirrhosis
|
Tonon, M.
|
|
2019
|
51 |
S1 |
p. e43
|
artikel
|
| 109 |
The development of hepatolocellular carcinoma is not predicted by genetic variants in caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 10 years
|
Loglio, A.
|
|
2019
|
51 |
S1 |
p. e56
|
artikel
|
| 110 |
The gain of function mutation of SerpinB3 (SCCA-PD) is associated with the severity portal hypertension and complications onset in patients with advanced liver disease
|
Martini, A.
|
|
2019
|
51 |
S1 |
p. e48
|
artikel
|
| 111 |
The impact of sustained virological response (SVR) on the criteria used to rule out high risk esophageal varices (HRV) in HCV-related compensated advanced chronic liver disease (cACLD)
|
Tosetti, G.
|
|
2019
|
51 |
S1 |
p. e46-e47
|
artikel
|
| 112 |
The influence of hepatic encephalopathy (HE) history, HE status and neuropsychological test type on learning ability in patients with cirrhosis
|
Zarantonello, L.
|
|
2019
|
51 |
S1 |
p. e46
|
artikel
|
| 113 |
The integration of Hepatitis B virus into human genome is a common event in the setting of HBeAg negative chronic infection: implications for an altered cell homeostasis and metabolism
|
Salpini, R.
|
|
2019
|
51 |
S1 |
p. e14
|
artikel
|
| 114 |
The natural history of acute kidney disease (AKD) in patients with cirrhosis
|
Tonon, M.
|
|
2019
|
51 |
S1 |
p. e10
|
artikel
|
| 115 |
The psychomotor vigilance task: role in the diagnosis of hepatic encephalopathy and relationship with driving ability
|
Formentin, C.
|
|
2019
|
51 |
S1 |
p. e47
|
artikel
|
| 116 |
The residual native albumin predicts albumin dysfunction and outcomes in hospitalized cirrhotic patients with acute decompensation or acute-on-chronic liver failure
|
Baldassarre, M.
|
|
2019
|
51 |
S1 |
p. e41
|
artikel
|
| 117 |
The risk of hepatic decompensation is reduced, but not abolished after direct-acting antivirals: the role of spleen stiffness measurement
|
Dajti, E.
|
|
2019
|
51 |
S1 |
p. e64
|
artikel
|
| 118 |
The role of alcoholic liver disease as risk factor for the development of de novo metabolic syndrome after liver transplantation: a prospective longitudinal study
|
Becchetti, C.
|
|
2019
|
51 |
S1 |
p. e51
|
artikel
|
| 119 |
The role of bile acids profile and insulin resistance for the prediction of gallbladder disease in a prospective cohort of blood donors
|
Azzaroli, F.
|
|
2019
|
51 |
S1 |
p. e21
|
artikel
|
| 120 |
The role of delta creatinine and serum albumin in predicting mortality in patients with severe alcoholic hepatitis and infection
|
Germani, G.
|
|
2019
|
51 |
S1 |
p. e29
|
artikel
|
| 121 |
The role of immune profile in patients with severe alcoholic hepatitis in predicting mortality and the development of infections: a prospective evaluation
|
Germani, G.
|
|
2019
|
51 |
S1 |
p. e31
|
artikel
|
| 122 |
The role of liver and spleen stiffness measurement in predicting hepatic decompensation after HCV eradication with direct-acting antiviral agents therapy
|
Dajti, E.
|
|
2019
|
51 |
S1 |
p. e64
|
artikel
|
| 123 |
The time-varying survival benefit of HCC treatment: a multicenter cohort study
|
Vitale, A.
|
|
2019
|
51 |
S1 |
p. e8
|
artikel
|
| 124 |
Three years of obeticholic Acid (OCA) therapy results in histological improvements in patients with primary biliary cholangitis: further analysis of the POISE Biopsy substudy
|
Bowlus, C.L.
|
|
2019
|
51 |
S1 |
p. e19
|
artikel
|
| 125 |
Time-varying mHAP III is the most accurate score in predicting survival in patients with hepatocellular carcinoma (HCC) undergoing trans-arterial chemoembolization (TACE)
|
Campani, C.
|
|
2019
|
51 |
S1 |
p. e6
|
artikel
|
| 126 |
TM6SF2 silencing impairs lipid metabolism and trafficking in HepG2 cells carrying the I148M PNPLA3 variant and MBOAT7 deletion
|
Longo, M.
|
|
2019
|
51 |
S1 |
p. e25
|
artikel
|
| 127 |
Transcriptomics highlights interleukin-32 a novel biomarker showing higher accuracy in carriers of the pnpla3 i148m variant
|
Baselli, G.A.
|
|
2019
|
51 |
S1 |
p. e30-e31
|
artikel
|
| 128 |
Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy
|
Pasulo, L.
|
|
2019
|
51 |
S1 |
p. e16-e17
|
artikel
|
| 129 |
Uncovering “hidden” mutations in hepatocellular carcinoma: the use of droplet digital PCR to detect TERT promoter mutations
|
Pezzuto, F.
|
|
2019
|
51 |
S1 |
p. e37
|
artikel
|
| 130 |
Very low prevalence of active HCV infection among healthcare workers in a regional reference hospital of Tuscany, Italy
|
Colombatto, P.
|
|
2019
|
51 |
S1 |
p. e63
|
artikel
|
| 131 |
Weighted gene co-expression network analysis of circulating miRNAs as a tool to discover prognostic biomarkers for hepatocelluar carcinoma
|
Pascut, D.
|
|
2019
|
51 |
S1 |
p. e33
|
artikel
|
Tijdschrift beschrijving